Poor ART Adherence, Understanding Threatening To Undermine Gains Against HIV/AIDS In Nepal

Though HIV prevalence in Nepal has dropped from 0.45 percent in 2005 to 0.3 percent in 2012, according to a new report (.pdf) from the government, “[p]oor understanding of antiretroviral therapy (ART) amongst health officials, clinicians and patients in Nepal could undermine [those] gains … and threaten future progress in lowering the number of new infections,” PlusNews reports. The news service interviews several Nepalese HIV/AIDS specialists about the importance of patients’ adherence to ART, how difficult travel to clinics can inhibit patients from returning for medication refills or counseling, and how “[p]olicies that neglect the comprehensive nutritional, financial, educational, and pharmaceutical needs of people living with HIV/AIDS amount to treatment illiteracy at the policy level.” PlusNews writes, “Observers fear the positive results from national HIV efforts could be diluted if tensions over the administration of HIV programs continue, and adherence issues hamper implementation” (4/17).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.